冠心病作为一种严重的心血管疾病，其挑战在于其高发病率、高致残率和高死亡率，给患者的健康和生命带来巨大威胁。治疗冠心病的关键在于早期诊断、合理治疗和长期管理，以降低心血管事件的风险，提高患者的生活质量。本届论坛将聚焦冠心病的最新诊疗技术和研究进展，为临床医生提供宝贵的学术交流和学习的平台。

The 18^th Oriental Congress of Cardiology (OCC 2024) and the World Congress of Cardiology (WCC 2024) are set to convene at the Shanghai International Convention Center from June 27- 30, 2024. Coronary heart disease (CHD) will serve as a core topic of this esteemed gathering, drawing numerous authoritative experts from home and abroad for in-depth discussions and exchanges.

CHD, a severe cardiovascular condition, poses significant challenges due to its high incidence, disability, and mortality rates, posing a grave threat to patients' health and lives. The crux of treating CHD lies in early diagnosis, rational treatment, and long-term management, aiming to reduce the risk of cardiovascular events and enhance patients' quality of life. This forum will focus on the latest diagnostic techniques and research advancements in CHD, providing clinicians with a valuable platform for academic exchange and learning.

• 论坛时间：2024年6月28/29日 星期五/六
• 论坛地点：上海国际会议中心黄河厅/明珠厅
• 论坛坛主：北京大学第一医院霍勇教授、新加坡国家心脏中心Jack Tan教授
• Forum Date: Friday/Saturday ,June 28/29, 2024 ；
• Forum Venue: Yellow River Hall/Pearl Hall, Shanghai International Conference Centre
• Forum Chairs:

Professor Yong Huo, Peking University First Hospital;

Professor Jack Tan, National Heart Centre Singapore

冠心病作为一种复杂而多变的疾病，其诊疗过程中确实面临着多项挑战。这些挑战不仅源于疾病本身的复杂性，还涉及到筛查和治疗的各个环节。

在首个主题环节，北京大学医学部心血管研究所的张岩教授与英国帝国理工学院国立心肺研究所的David Wood教授将分别通过具体案例介绍冠心病筛查和治疗中面临的挑战，同时凭借丰富的临床经验和专业知识，为临床医生提供宝贵的实践经验和指导。

此外，来自香港大学的谢鸿发教授将带来一例冠心病易被忽视病因的分析。患者的病情往往错综复杂，通过具体案例的解析，临床医生可以学习如何在面对模糊、复杂或疑难的临床症状时，通过系统性分析、综合判断，最终找出病因。

Coronary heart disease, as a complex and diverse illness, indeed confronts numerous challenges throughout its diagnostic and therapeutic process. These challenges stem not only from the intricacies of the disease itself but also extend to every facet of screening and treatment.

During the opening session, Professor Zhang Yan from the Cardiovascular Institute of Peking University Medical School and Professor David Wood from the National Heart and Lung Institute at Imperial College London will each present on the challenges encountered in the screening and treatment of coronary heart disease. Leveraging their vast clinical experience and professional expertise, they will provide invaluable practical insights and guidance to clinicians.

针对冠心病的治疗策略，美国的Richard Chazal教授将借助实际案例介绍CT与AI技术在冠心病斑块治疗追踪中的创新应用，助力医生实现精准治疗，为冠心病患者提供更为个性化的治疗方案。

此外，美国的Jagat Narula教授也将根据实例为我们详细解读冠心病中的心肌缺血及冠状动脉微血管功能障碍，为临床医生提供更全面的诊疗建议，从而改善患者医疗服务。

Regarding the treatment strategies for coronary heart disease, Professor Richard Chazal from the US will introduce the innovative application of CT and AI technology in tracking the treatment of coronary artery plaques, assisting doctors in achieving precision therapy, and providing more personalized treatment plans for patients with coronary heart disease.

Additionally, Professor Jagat Narula from the US will elaborate on myocardial ischemia and coronary microvascular dysfunction in coronary heart disease, providing clinicians with more comprehensive diagnostic and treatment recommendations to improve patient care.

针对冠心病的地域性差异，亚洲与世界其它地区的心血管疾病预测显得尤为重要。在第二个主题环节中，作为亚洲代表，赵冬教授将重点阐述中国冠心病的高质量护理，Michael Lim教授则将详细介绍新加坡针对人口老龄化冠心病的有效实施模型，为其他国家应对类似问题提供了借鉴。

放眼全球，英国的Andreas Baumbach教授将分享欧洲国家在介入心脏病学领域的谱系和发展，美国的Thomas Gaziano教授则将阐述针对高血压与血脂异常等关键风险因素的有效实施模型。这些国际经验也为全球心血管疾病的预防和治疗提供了新的思路。

此外，英国的David Wood教授将探讨INTERASPIRE研究的最新发现，为心血管疾病的研究和治疗提供了更多有价值的参考。

Given the geographical differences in coronary heart disease, the prediction of cardiovascular diseases in Asia and other regions of the world becomes particularly important. In the second segment, as a representative from Asia, Professor Zhao Dong will focus on the high-quality care of coronary heart disease in China, while Professor Michael Lim will introduce Singapore's effective implementation model for coronary heart disease in the context of population aging, providing a reference for other countries facing similar issues.

Globally, Professor Andreas Baumbach from the UK will share the lineage and development of interventional cardiology in European countries, and Professor Thomas Gaziano from the US will elaborate on effective implementation models targeting key risk factors such as hypertension and dyslipidemia. These international experiences also provide new insights for the prevention and treatment of global cardiovascular diseases.

Moreover, Professor David Wood from the UK will explore the latest findings of the INTERASPIRE study, providing more valuable references for the research and treatment of cardiovascular diseases.

We eagerly anticipate the convening of the OCC-WCC 2024 Coronary Disease Forum, looking forward to the in-depth exchanges among experts at the forum, jointly exploring new ideas and methods in coronary heart disease diagnosis and treatment strategies, collaborating to promote academic progress in the field of coronary heart disease treatment, and bringing more precise and effective treatment plans to patients!